Stevenage, United Kingdom

Preeti Bakrania

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Preeti Bakrania: Innovator in Antibody Research

Introduction

Preeti Bakrania is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of antibody research, particularly focusing on the development of anti-TauC3 antibodies. With a total of 2 patents to her name, her work is paving the way for advancements in medical science.

Latest Patents

Her latest patents include "Anti-TauC3 antibodies and uses thereof" and "Anti-TAUC3 antibodies and uses thereof." These patents describe anti-TauC3 antibodies that are at least several orders of magnitude more specific for TauC3 than for full-length tau (2N4R). Additionally, the patents outline methods for utilizing these anti-TauC3 antibodies, showcasing their potential applications in therapeutic settings.

Career Highlights

Throughout her career, Preeti has worked with various companies, including Tauc3 Biologies Limited and Tauc3 Biologics Limited. Her innovative research has positioned her as a key figure in the biotechnology sector, contributing to the understanding and treatment of tau-related diseases.

Collaborations

Preeti has collaborated with notable professionals in her field, including Daniel G Chain and Seema Patel. These partnerships have further enhanced her research and development efforts, leading to impactful advancements in antibody technology.

Conclusion

Preeti Bakrania's work in the development of anti-TauC3 antibodies represents a significant advancement in medical research. Her contributions are expected to have lasting effects on the treatment of tau-related conditions, highlighting her role as an influential inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…